A. Papi (Ferrara, Italy), P. Bardin (Melbourne, Australia)
Influenza type A outbreak associated with myositis
K. A. Gaber, C. Snelson, J. Talbot, C. D. Sheldon (Exeter, United Kingdom)
|   |
Blood and BAL T cell cytokine production during RV16 infection in normal and asthmatic human volunteers
S. Message, V. Laza-Stanca, P. Mallia, T. Kebadze, J. Zhu, L. Stanciu, P. Jeffrey, S. Johnston (London, United Kingdom)
| |
Virusologic research in healthy persons of closed collectives
N. Yakovleva, T. Sologub, S. Zhogolev, P. Ogarkov, N. Zueva (St. Petersburg, Russian Federation)
| |
Modulation of human macrophage IL-15 production by respiratory syncytial virus
V. Laza-Stanca, K. Wong, M. R. Edwards, M. T. Zdrenghea, L. A. Stanciu, S. L. Johnston (London, United Kingdom)
| |
Nitric oxide gas: a potential respiratory antiviral
C. Miller, A. Schaefer, B. Perry, N. Cook (Tofield, Lacombe, Canada)
| |
Rhinovirus induces airway fibroblast release of neutrophil but not eosinophil chemokines
R. Ghildyal, H. Dagher, M. Lindsay, S. Barrett, N. J. Freezer, P. G. Bardin (Melbourne, Australia)
| |
Impaired viral clearance after influenza infection in IDO transgenic mice
K. F. van der Sluijs, M. Snoek, T. van der Poll, H. M. Jansen, R. Lutter (Amsterdam, Netherlands)
| |
Vaccinating children against influenza: a systematic review of the evidence for community protection
R. Jordan, M. Connock, E. Albon, A. Fry-Smith, A. Burls, B. Olowokure, J. Hawker (Birmingham, United Kingdom)
| |